About Our Sponsor

PGD (Personal Genome Diagnostic)

Personal Genome Diagnostic (PGD) represents an advanced precision-health solution provider specializing in genetic analysis, predictive diagnostics, and personalized health insights. By leveraging genomic sequencing, bioinformatics, and AI-driven interpretation, PGD empowers healthcare providers, researchers, and individuals to understand genetic predispositions, optimize preventive care, and enable data-driven medical decision-making.

Campaign Objective

PGD partnered with Group Futurista to host a targeted virtual healthcare innovation summit designed to:

  • Engage senior healthcare, biotech, and clinical research leaders
  • Showcase the clinical and preventive value of genomic diagnostics
  • Generate high-quality leads from medical and research institutions
  • Position PGD as a thought leader in precision medicine and personalized healthcare

Target Audience Roles

  • Chief Medical Officers 
  • Clinical Geneticists 
  • Healthcare Innovation Directors 
  • Laboratory Heads 
  • Precision Medicine Specialists 
  • Hospital Administrators 
  • Research Scientists 
  • Biotechnology Executives

Event Metrics

Metric Result
Total Registrations 412+
Live Attendance 48% (approx. 198 attendees)
On-Demand Views 321+ within 30 days
Industries Represented 24 sectors
Director Level & Above 79%

Event Delivery & Engagement


The summit featured:

  • Strategic keynote on the future of genomic medicine
  • Executive panel on integrating genetic testing into clinical workflows
  • Live demonstration of PGD diagnostic platform capabilities
  • Interactive polling on adoption barriers in precision healthcare
  • Real-time Q&A and curated networking sessions

Engagement Highlights

  • Strong participation from clinical and research decision-makers
  • 84 audience questions submitted live
  • Average viewing duration: 51 minutes
  • Peak engagement during live diagnostic platform demo
  • Active discussions on regulatory, ethical, and implementation challenges

Lead Quality & Conversations Generated

Qualified Leads Delivered: 214 MQLs

Lead Profile

  • Hospitals implementing precision medicine programs
  • Diagnostic labs expanding genomic testing services
  • Research institutions exploring genetic data analytics
  • Healthcare organizations adopting predictive diagnostics

Key Conversation Themes

  • Improving early disease detection through genetics
  • Integrating genomic data with patient records
  • Enhancing personalized treatment strategies
  • Scaling clinical genetic testing services
  • Addressing compliance and data privacy requirements

Post-Event Interest Signals

Participants requested:

  • Platform demonstrations
  • Clinical validation data
  • Partnership discussions
  • Pilot program trials

Results Snapshot

KPI Outcome
Qualified Leads 214
Senior Decision Makers 79%
Avg Engagement 51 mins
Questions Asked 84
Follow-Up Requests Very Strong
Pipeline Potential High

Outcome

Through this focused virtual leadership summit, PGD successfully:

  • Engaged high-intent healthcare and biotech leaders
  • Strengthened positioning as a precision-medicine innovator
  • Generated strong enterprise-level pipeline opportunities
  • Initiated strategic collaborations with qualified prospects
  • Achieved measurable campaign ROI from a single partnership initiative
Recording (Full session recording)